Generic Sweden ABOMXSTO: GENI

GENI: Strong EBIT growth and improved margins in Q2 2025, led by SaaS and secure communication services

· Issued by Generic Sweden AB

Q2 2025 saw revenue rise 2.1% and EBIT jump 33.6%, with gross margin up to 43.8%. SaaS and secure communication services drove profitability, while cash flow from operations improved significantly. Healthcare and e-health segments expanded, offsetting slower e-commerce growth.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Generic Sweden AB on 6ix

Story so far

Earlier from Generic Sweden

Later from Generic Sweden

All Generic Sweden news releases